These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2360263)

  • 1. Effects of prazosin therapy in renal allograft recipients receiving cyclosporine.
    Kiberd BA
    Transplantation; 1990 Jun; 49(6):1200-1. PubMed ID: 2360263
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe endothelial injury in a renal transplant patient receiving cyclosporine.
    Fogo A; Hakim RC; Sugiura M; Inagami T; Kon V
    Transplantation; 1990 Jun; 49(6):1190-2. PubMed ID: 2193445
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine-associated hypertension in cardiopulmonary transplantation. The beneficial effect of nifedipine on renal function.
    Kirk AJ; Omar I; Bateman DN; Dark JH
    Transplantation; 1989 Sep; 48(3):428-30. PubMed ID: 2675400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine nephrotoxicity and the role of cyclosporine in living-related donor transplantation.
    Paller MS
    Am J Kidney Dis; 1990 Nov; 16(5):414-6. PubMed ID: 2239930
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic irreversible nephrotoxicity from cyclosporin A.
    Rao KV; Crosson JT; Kjellstrand CM
    Nephron; 1985; 41(1):75-7. PubMed ID: 3897887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine.
    Barton CH; Vaziri ND; Martin DC; Choi S; Alikhani S
    Am J Med; 1987 Oct; 83(4):693-9. PubMed ID: 3314493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
    O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450
    [No Abstract]   [Full Text] [Related]  

  • 8. Case presentations in renal transplantation.
    Kahan BD
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):70-96. PubMed ID: 2662537
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
    J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of cyclosporine on the practice of renal transplantation.
    Kahan BD
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):63-9. PubMed ID: 2545019
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrotoxicity of cyclosporine in liver transplantation.
    Iwatsuki S; Esquivel CO; Klintmalm GB; Gordon RD; Shaw BW; Starzl TE
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):191-5. PubMed ID: 3895661
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients.
    Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged oliguric renal failure related to cyclosporin A in a renal transplant recipient.
    Bear R; Walker F; Lang A
    Am J Nephrol; 1983; 3(5):293-4. PubMed ID: 6356922
    [No Abstract]   [Full Text] [Related]  

  • 14. Glomerulotubular function in long-term renal allograft recipients. A comparison of conventional therapy with cyclosporine.
    Propper DJ; Whiting PH; Mackay J; Catto GR
    Transplantation; 1990 Jul; 50(1):72-5. PubMed ID: 2368153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption profiles of renal allograft recipients receiving oral doses of cyclosporine: a pharmacokinetic study.
    Phillips TM; Karmi SA; Frantz SC; Henriques HF
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):457-61. PubMed ID: 3284090
    [No Abstract]   [Full Text] [Related]  

  • 16. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for the development of chronic cyclosporine-nephrotoxicity.
    Mihatsch MJ; Steiner K; Abeywickrama KH; Landmann J; Thiel G
    Clin Nephrol; 1988 Apr; 29(4):165-75. PubMed ID: 3284669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous heparin therapy for cyclosporine-immunosuppressed renal allograft recipients.
    Ubhi CS; Lam FT; Mavor AI; Giles GR
    Transplantation; 1989 Nov; 48(5):886-7. PubMed ID: 2815265
    [No Abstract]   [Full Text] [Related]  

  • 19. Cotton-wool exudates not observed in recipients of renal transplants treated with cyclosporine.
    Oechslin M; Thiel G; Landmann J; Gloor B
    Transplantation; 1986 Jan; 41(1):60-2. PubMed ID: 3510496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results.
    Kelly JJ; Walker RG; d'Apice AJ; Kincaid-Smith P
    Transplant Proc; 1990 Oct; 22(5):2127-8. PubMed ID: 2219318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.